Company Search:
Advanced Search
Sponsored Links
Liminal BioSciences Inc Company Snapshot
Liminal BioSciences Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Liminal BioSciences Inc with three other companies in this sector in CANADA : Pond Technologies Holdings Inc (2020 sales of 4.80 million Canadian Dollars [US$3.76 million] of which 92% was Nutraceutical Products), VBI Vaccines Inc (1.42 million Canadian Dollars [US$1.11 million] of which 73% was R&D Service revenue), and IBEX Technologies Inc (5.21 million Canadian Dollars [US$4.08 million] ).

Sales Analysis. Sales levels dropped significantly in the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at Liminal BioSciences Inc totalled C$25,000.00 . This is a drop of 95.4% from the C$540,000.00 in sales at the company during the second quarter in 2020. During the first two quarters of 2021, sales totalled C$235,000.00 , which is 85.7% lower than through the first two quarters of 2020. Liminal BioSciences Inc reported sales of C$3.32 million (US$2.60 million) for the year ending December of 2020. This represents a sharp decrease of 32.4% versus 2019, when the company's sales were C$4.90 million. Contributing to the drop in overall sales was the 85.3% decline in Small Mole Cule, from C$34,000.00 to C$5,000.00 . There were also decreases in sales in Plasma Derived Therapeutics (down 45.1% to C$2.60 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Liminal BioSciences Inc
  Stock Performance Chart for Liminal BioSciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): 3.43
(Figures in Canadian Dollars)
1 Week 5.9%   13 Weeks 24.3%  
4 Weeks -35.1%   52 Weeks -78.3%  
Liminal BioSciences Inc Key Data:
  Ticker: LMNL Country: Canada
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 3,317,000
(Year Ending Jan 2021).
Employees: 251
  Currency: Canadian Dollars Market Cap: 102,596,576
  Fiscal Yr Ends: December Shares Outstanding: 29,943,839
  Share Type: Common Closely Held Shares: 19,883,898
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.